Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much ...
The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin ...
A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side effects.
Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...
The White House on Friday said Novo Nordisk’s weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a ...
The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...